Stephen Parker

Stephen Parker

Fortune : 184 194 $ au 31/08/2026

67 ans
Health Technology
Finance
Commercial Services

Profil

Dr. Stephen B. Parker is a Non-Executive Chairman at Biodexa Pharmaceuticals Plc, a Non-Executive Chairman at Drishti Discoveries Ltd., an Executive Chairman at Sareum Holdings Plc and a Partner at Celtic Pharma Management LP.
He is on the Board of Directors at Eternans Ltd., Sp2 Asset Management Ltd., Sareum Ltd. and Sp2 Consulting Ltd. Dr. Parker was previously employed as a Non-Executive Chairman by MGC Pharmaceuticals Ltd., a Chairman by Liverpool Chirochem Ltd., an Independent Non-Executive Director by Silence Therapeutics Plc, a Partner by Beehive Capital LLP, a Non-Executive Chairman by Physiomics Plc, a Principal by Celtic Pharma Holdings Advisors LLP, a Chief Financial Officer by Oxford GlycoSciences Plc, a Chairman by Ah Animal Healthcare Ltd., a Principal by Apax Partners LLP, a Principal by Barings Plc, a Head-Partner Network, Research & Development by Bedford Royalties Ltd., a Non-Executive Director by Gammadelta Therapeutics Ltd., a Consultant by PA Consulting Group Holdings Ltd., a Co-Founder by UK Stem Cell Foundation, and a Principal by Warburg Group Plc.
He also served on the board at Albucasis Ltd., Celtic Pharma Development UK Plc, Celtic Pharma GP Ltd., Houlihan Lokey Advisory Ltd., Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Group Plc and Xenova Ltd. He received his undergraduate degree from the University of East Anglia, an MBA from Bayes Business School and a doctorate degree from the University of Oxford.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/03/2025 405 045 ( 0,29 % ) 184 194 $ 31/08/2026
12/03/2026 0 ( -.--% ) - $ 31/08/2026

Postes actifs de Stephen Parker

SociétésPosteDébut
BIODEXA PHARMACEUTICALS PLC Président 20/06/2022
SAREUM HOLDINGS PLC Président 17/05/2016
Sp2 Consulting Ltd.
Directeur/Membre du Conseil -
Eternans Ltd.
Directeur/Membre du Conseil 01/07/2019
Président 01/01/2021
Directeur/Membre du Conseil -
Sp2 Asset Management Ltd.
Directeur/Membre du Conseil 01/09/2018
Private Equity Investor 01/04/2005

Anciens postes connus de Stephen Parker

SociétésPosteFin
ARGENT BIOPHARMA LIMITED Président 01/12/2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Stephen Parker

Formation de Stephen Parker

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

33

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées33

Commercial Services

Miscellaneous

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Finance

Finance

Consumer Services

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Xenova Ltd.

Commercial Services

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

  1. Bourse
  2. Insiders
  3. Stephen Parker
🔇